Raia Drogasil S.A.

RADLY

RADLYRaia Drogasil S.A. US flag

Other OTC

2.49

USD

-0.04

(-1.58%)

0.13EPS

19.15P/E

4.27BMarket Cap

Aug 05Next Earn

Upgrade to Unlock Non-US CompaniesTo view real-time data and analysis of companies outside of the United States, upgrade your account to our premium subscription.

Upgrade

ISIN

US7507231089

CUSIP

750723108

Return %

Stock

S&P500

-44.04

9.50

-31.22

58.73

-42.09

91.32

Use logarithmic scale

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	TTM
Revenue per Share	3.13	3.63	4.29	5.19	6.56	7.71	8.64	10.25	11.7	14.07	17.64	20.84	23.57	23.84
Basic EPS, GAAP	0.06	0.06	0.13	0.2	0.26	0.3	0.29	0.45	0.28	0.44	0.6	0.65	0.73	0.7
Free Cash Flow per Basic Share	-0.09	0.04	0.04	0.07	0.04	-0.01	-0.01	0.27	0.47	0.41	-0.21	-0.21	0.38	0.26
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Book Value per Share	0.53	0.53	0.53	1.06	1.05	1.05	1.06	1.46	1.46	1.46	1.52	2.45	2.43	2.42
Tangible Book Value per Share	0.64	0.68	0.78	0.87	1.03	1.2	1.36	1.65	1.84	1.88	2.22	2.52	2.68	2.68
Basic Weighted Avg Shares	1,718	1,718	1,713	1,713	1,715	1,714	1,713	1,713	1,715	1,715	1,648	1,630	1,649	1,670
Sales/Revenue/Turnover	5,381	6,233	7,351	8,898	11,257	13,213	14,801	17,566	20,067	24,127	29,067	33,974	38,864	39,815
Operating Margin (%)	2.99	2.4	4.66	5.63	6.27	6	5.18	5.07	4.46	5.69	6.42	5.75	6.09	5.84
Depreciation Expense	124	159	188	228	274	338	414	1,041	1,177	1,327	700	798	912	961
Net Income, GAAP	105	101	221	340	448	511	502	772	484	752	996	1,055	1,198	1,174
Effective Tax Rate (%)	33.67	27.55	26.75	22.05	24.19	25.33	20.28	- -	19.6	22.6	14.94	10.65	14.59	11.61
Profit Margin (%)	1.95	1.62	3.01	3.82	3.98	3.87	3.39	4.4	2.41	3.12	3.43	3.11	3.08	2.95
Working Capital	831	884	969	1,037	1,243	1,434	1,616	1,678	2,219	1,823	3,210	3,482	3,480	3,362
LT Debt	131	161	184	188	281	415	570	3,516	4,050	3,865	5,112	5,604	6,110	5,992
Total Equity	2,265	2,327	2,457	2,657	2,936	3,250	3,535	4,076	4,426	4,719	5,403	6,028	6,442	6,501
Return on Invested Capital (%)	4.33	4.22	9.27	13.51	16.6	15.93	14.46	- -	7.94	10.8	14.64	13.93	14.49	14.68
Return on Capital (%)	10.6	10.14	20.43	22.15	22.29	23.86	21.12	- -	9.67	12.81	17.78	17.02	16.46	16.28
Return on Common Equity (%)	11.54	11.11	24.36	25.04	24.75	28.26	27.78	35.85	19.38	30.08	39.84	32.46	29.94	28.76

Capital Structure

•

in mil. unless spec.

Working Capital

•

in mil. unless spec.

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)	10 years	5 years	1 year
Sales/Revenue/Turnover	18.19%	17.25%	14.4%
Net Income, GAAP	22.13%	13.97%	13.53%
Free Cash Flow	-278.26%	-75.02%	-283.87%
Total Cash Common Dividend	- -	- -	- -
Total Equity	10.16%	9.63%	6.87%

Growth Rates

•

in mil. unless spec.

Quarterly Revenue

•

in mil. unless spec.

Quarterly Earnings Per Share

•

in mil. unless spec.

Quarterly Dividends Per Share

•

in mil. unless spec.

Company Description

CEO: Mr. Renato Cepollina Raduan
Full Time Employees: 66,275
Sector: Healthcare
Industry: Medical - Pharmaceuticals
Address: Av. Corifeu de Azevedo Marques, 3097 São Paulo SP Brazil 05.339-900
IPO Date: Jul 19, 2016
Website: rd.com.br
Similar Companies: Universal Health International Group Holding Limited (2211.HK)
BeiGene, Ltd. (6160.HK)
Caraco Pharmaceutical Laboratories Ltd (CPD)
MDxHealth SA (0O8G.L)
Bristol-Myers Squibb Company (BMY.SW)
COSMOS Pharmaceutical Corporation (CSMYF)
Business: Raia Drogasil S.A. engages in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics, dermocosmetics, and specialty medicines in Brazil. As of March 31, 2022, the company operated a network of 2,530 drug stores in 26 Brazilian states. It also markets its goods through telesales and its three call centers in the states of São Paulo, Tocantins, and Pernambuco. The company was founded in 1905 and is headquartered in São Paulo, Brazil.

Company News

seekingalpha.com
a month ago
Raia Drogasil: Valuation Burn Now, Healthy Gains Later
investorplace.com
a year ago
What's Hot, What's Not: China Stocks Are Out. Top Picks From 3 Other Countries
investorplace.com
2 years ago
3 Stocks to Ride the Latin America Market Boom in 2024
investorplace.com
2 years ago
The 3 Best South American Stocks to Buy in 2023

	Sep'24	Dec'24	Mar'25
ST Debt	1,566	1,585	1,726
LT Borrowings	2,655	2,657	2,408
LT Finance Leases	3,348	3,453	3,583
Preferred Equity and Hybrid Capital	- -	- -	- -
Shares Outstanding	1,715	1,712	1,713
Market Capitalization	43,807	33,670	35,026

	Sep'24	Dec'24	Mar'25
Total Current Assets	12,890	12,704	13,108
Accounts Receivable, Net	3,363	2,667	2,827
Cash, Cash Equivalents & STI	411	544	470
Inventories	8,133	8,407	8,601
Total Current Liabilities	9,298	9,223	9,746
Payables & Accruals	- -	- -	- -
ST Debt	1,566	1,585	1,726
Deferred Revenue	- -	- -	- -

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	TTM
Revenue per Share	3.13	3.63	4.29	5.19	6.56	7.71	8.64	10.25	11.7	14.07	17.64	20.84	23.57	23.84
Basic EPS, GAAP	0.06	0.06	0.13	0.2	0.26	0.3	0.29	0.45	0.28	0.44	0.6	0.65	0.73	0.7
Free Cash Flow per Basic Share	-0.09	0.04	0.04	0.07	0.04	-0.01	-0.01	0.27	0.47	0.41	-0.21	-0.21	0.38	0.26
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Book Value per Share	0.53	0.53	0.53	1.06	1.05	1.05	1.06	1.46	1.46	1.46	1.52	2.45	2.43	2.42
Tangible Book Value per Share	0.64	0.68	0.78	0.87	1.03	1.2	1.36	1.65	1.84	1.88	2.22	2.52	2.68	2.68
Basic Weighted Avg Shares	1,718	1,718	1,713	1,713	1,715	1,714	1,713	1,713	1,715	1,715	1,648	1,630	1,649	1,670
Sales/Revenue/Turnover	5,381	6,233	7,351	8,898	11,257	13,213	14,801	17,566	20,067	24,127	29,067	33,974	38,864	39,815
Operating Margin (%)	2.99	2.4	4.66	5.63	6.27	6	5.18	5.07	4.46	5.69	6.42	5.75	6.09	5.84
Depreciation Expense	124	159	188	228	274	338	414	1,041	1,177	1,327	700	798	912	961
Net Income, GAAP	105	101	221	340	448	511	502	772	484	752	996	1,055	1,198	1,174
Effective Tax Rate (%)	33.67	27.55	26.75	22.05	24.19	25.33	20.28	- -	19.6	22.6	14.94	10.65	14.59	11.61
Profit Margin (%)	1.95	1.62	3.01	3.82	3.98	3.87	3.39	4.4	2.41	3.12	3.43	3.11	3.08	2.95
Working Capital	831	884	969	1,037	1,243	1,434	1,616	1,678	2,219	1,823	3,210	3,482	3,480	3,362
LT Debt	131	161	184	188	281	415	570	3,516	4,050	3,865	5,112	5,604	6,110	5,992
Total Equity	2,265	2,327	2,457	2,657	2,936	3,250	3,535	4,076	4,426	4,719	5,403	6,028	6,442	6,501
Return on Invested Capital (%)	4.33	4.22	9.27	13.51	16.6	15.93	14.46	- -	7.94	10.8	14.64	13.93	14.49	14.68
Return on Capital (%)	10.6	10.14	20.43	22.15	22.29	23.86	21.12	- -	9.67	12.81	17.78	17.02	16.46	16.28
Return on Common Equity (%)	11.54	11.11	24.36	25.04	24.75	28.26	27.78	35.85	19.38	30.08	39.84	32.46	29.94	28.76

Year	Q1	Q2	Q3	Q4	FY
2023	7,931	8,442	8,676	8,924	33,974
2024	9,100	9,687	9,989	10,088	38,864
2025	10,051	- -	- -	- -	- -

Year	Q1	Q2	Q3	Q4	FY
2023	0.12	0.2	0.16	- -	0.65
2024	0.11	0.19	0.2	- -	0.73
2025	0.1	- -	- -	- -	- -

Raia Drogasil S.A.

Growth Rates

(avg. rate of change)

Company Description

Company News

Growth Rates

(avg. rate of change)

Capital Structure

Working Capital

Quarterly Revenue

Year

Quarterly Dividends Per Share

Year

Quarterly Earnings Per Share

Year